Unknown PHASE3 INTERVENTIONAL 4-arm NCT05591872

Low Dose Heparin Factorial Trial

Low Dose Versus High Dose Heparin With or Without Hemostasis Patch and Radial Access Site Outcomes; an Open-label Factorial Randomized Trial (InnoSEAL III)

Sponsor: InnoTherapy Inc

Conditions Radial Artery Occlusion

Interventions LD+I+TRB

Updated 4 times since 2022 Last updated: Oct 19, 2022 Started: May 9, 2022 Primary completion: Apr 30, 2023 Completion: Oct 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Radial Artery Occlusion, this trial is ongoing. The trial is conducted by InnoTherapy Inc and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Nov 2024 — Present [monthly]

Unknown PHASE3

Status: Recruiting → Unknown
Sep 2024 — Nov 2024 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Nov 2022 — Jul 2024 [monthly]

Recruiting PHASE3

First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

InnoTherapy Inc
Tabba Heart Institute

Data source: Tabba Heart Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan